查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1738666

全球治療性疫苗市場規模（依目標疾病、作用方式、給藥機制、地區、範圍及預測）

Global Therapeutic Vaccines Market Size By Type of Disease Targeted, By Mode of Action, By Delivery Mechanism, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

治療性疫苗市場規模及預測

2024 年治療性疫苗市場規模價值為 473.3 億美元，預計到 2032 年將達到 1,782.6 億美元，2026 年至 2032 年的複合年成長率為 18.03%。

推動全球治療性疫苗市場的因素

  • 慢性病盛行率不斷上升：隨著癌症、愛滋病毒/愛滋病和自體免疫疾病等慢性病在全球的盛行率不斷上升，治療性疫苗市場的需求受到慢性病盛行率不斷上升、免疫療法市場發展、政府措施和資金以及技術創新的推動。

作為一種可能的治療選擇，它正變得越來越重要。

  • 免疫療法發展：近年來，免疫療法領域取得了重大突破，包括治療性疫苗。隨著新型疫苗平台的建立以及對免疫反應認知的不斷加深，治療性疫苗市場正在不斷擴大。
  • 政府措施與資金：世界各國政府和監管機構正在投入越來越多的資源用於治療性疫苗的研發。資金支持、政府核准以及疫苗研發獎勵推動市場的發展。
  • 技術創新：佐劑技術、疫苗設計方法和疫苗傳遞系統的進步，促進了更有效、更精準的治療性疫苗的研發。這些進步提高了治療性疫苗的安全性和臨床療效，推動了市場的發展。
  • 個人化醫療日益受到關注：治療性疫苗能夠根據每位患者獨特的免疫學和遺傳特徵制定個人化治療方案。個人化醫療趨勢推動了治療性疫苗在精準醫療中的應用。
  • 製藥公司加大研發支出：為了滿足尚未滿足的醫療需求並實現產品線多樣化，製藥公司正在大力投資治療性疫苗的研發。生物製藥領域的策略聯盟、夥伴關係和收購正在進一步推動市場擴張。
  • 加強患者教育和認知：推動市場發展的動力源於患者和醫療保健專業人員對治療性疫苗在治療慢性疾病方面的益處的認知不斷提高。宣傳工作和病患教育計畫將有助於更廣泛地接受和使用治療性疫苗。
  • 全球健康威脅與流行病：新興感染疾病和全球健康風險，例如COVID-19疫情，凸顯了疫苗研究和疫苗宣傳活動的重要性。治療性疫苗開發的投資源自於盡快對抗感染疾病的需求。

限制全球治療性疫苗市場的因素

  • 監管挑戰：治療性疫苗的核准需要遵守嚴格的法規，這可能會延遲新治療方法的推出。
  • 發現成本高：由於疫苗製造的複雜性和需要進行臨床試驗，治療性疫苗的研發通常非常昂貴，這可能會限制願意在該領域投資的公司數量。
  • 有效性有限：某些治療性疫苗對某些患者群體或疾病的有效性可能有限，這可能會限制其可接受性和適銷性。
  • 製造複雜性：生產治療性疫苗通常涉及複雜的步驟，這會對成本效益、擴充性和一致性帶來挑戰。
  • 患者接受度和依從性：讓患者接受並堅持治療性疫苗接種可能具有挑戰性，尤其是在需要頻繁接種疫苗或有嚴重副作用的情況下。
  • 與其他治療方法的衝突：傳統藥物療法和其他生物製藥可能提供治療疾病的其他方法，並可能對治療性疫苗接種構成威脅。
  • 知識和教育有限：患者和醫療保健專業人員對治療性疫苗及其益處的無知可能會阻礙治療性疫苗企業的發展。
  • 醫療保健基礎設施挑戰：由於缺乏醫療保健資源和基礎設施，治療性疫苗的分發和管理在某些地區可能會面臨挑戰。
  • 覆蓋範圍和報銷問題：覆蓋範圍和報銷不足可能會阻礙患者獲得和使用治療性疫苗，特別是在以私人醫療保健系統為主的地區。

目錄

第1章 引言

  • 市場定義
  • 市場區隔
  • 調查方法

第2章執行摘要

  • 主要發現
  • 市場概覽
  • 市場亮點

第3章市場概述

  • 市場規模和成長潛力
  • 市場趨勢
  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析

第4章 治療性疫苗市場（依目標疾病）

  • 感染疾病
  • 癌症
  • 自體免疫疾病

5. 治療性疫苗市場（依作用機轉）

  • 免疫調變器
  • 抗原特異性疫苗
  • 細胞疫苗

6. 治療性疫苗市場（依遞送機制）

  • 常規疫苗
  • 奈米顆粒疫苗
  • 基因疫苗

第7章區域分析

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第8章市場動態

  • 市場促進因素
  • 市場限制
  • 市場機會
  • COVID-19 市場影響

第9章 競爭態勢

  • 主要企業
  • 市場佔有率分析

第10章 公司簡介

  • Merck & Co.
  • GlaxoSmithKline
  • Pfizer
  • Moderna
  • BioNTech
  • Inovio Pharmaceuticals

第11章 市場展望與機會

  • 新興技術
  • 未來市場趨勢
  • 投資機會

第12章 附錄

  • 簡稱列表
  • 來源和參考文獻
簡介目錄
Product Code: 35680

Therapeutic Vaccines Market Size And Forecast

Therapeutic Vaccines Market size was valued at USD 47.33 Billion in 2024 and is projected to reach USD 178.26 Billion by 2032, growing at a CAGR of 18.03% during the forecast period 2026-2032.

Global Therapeutic Vaccines Market Drivers

The market drivers for the Therapeutic Vaccines Market can be influenced by various factors. These may include:

  • Increasing Prevalence of Chronic Diseases: With the prevalence of chronic illnesses including cancer, HIV/AIDS, and autoimmune disorders rising worldwide, therapeutic vaccinations aThe need for Therapeutic Vaccines Market is driven by Increasing Prevalence of Chronic Diseases, Developments in Immunotherapy, Government Initiatives and Funding and Technological Innovations

re becoming more and more important as a possible therapy option.

  • Developments in Immunotherapy: In recent years, there have been notable breakthroughs in the field of immunotherapy, which includes therapeutic vaccinations. The market for therapeutic vaccines is growing as a result of the creation of new vaccine platforms and enhanced knowledge of immune responses.
  • Government Initiatives and Funding: Around the world, governments and regulatory agencies are spending more money on the development of therapeutic vaccines. Market expansion is facilitated by financial assistance, government approvals, and incentives for vaccine development.
  • Technological Innovations: The creation of more effective and focused therapeutic vaccines has been made possible by developments in adjuvant technology, vaccine design approaches, and vaccine delivery systems. By improving the safety and clinical efficacy of therapeutic vaccines, these developments propel the market's growth.
  • Increasing Interest in Personalised Medicine: Therapeutic vaccinations present the possibility of individualised treatment plans that are based on the unique immunological and genetic profiles of each patient. The use of therapeutic vaccinations in precision medicine methods is driven by the trend towards personalised medicine.
  • Growing Pharmaceutical Companies' R&D Expenditures: Due to their potential to fill unmet medical needs and diversify product lines, pharmaceutical companies are making significant investments in the research and development of therapeutic vaccines. In the biopharmaceutical sector, strategic alliances, partnerships, and acquisitions propel market expansion even further.
  • Growing Patient Education and Awareness: The market is driven by patients' and healthcare professionals' increasing knowledge of the advantages of therapeutic vaccinations in the treatment of chronic illnesses. Advocacy and patient education programmes can make therapeutic vaccinations more widely accepted and used.
  • Global Health Threats and Pandemics: Emerging infectious illnesses and global health risks, like the COVID-19 pandemic, underscore the significance of vaccine research and vaccination campaigns. Investments in the development of therapeutic vaccines are motivated by the need to combat infectious diseases as soon as possible.

Global Therapeutic Vaccines Market Restraints

Several factors can act as restraints or challenges for the Therapeutic Vaccines Market. These may include:

  • Regulatory Difficulties: The approval of therapeutic vaccines must comply with strict regulations, which might cause delays in the launch of new treatments.
  • substantial creation expenses: Due to the complexity of vaccine creation and the requirement for clinical trials, research and development expenses for therapeutic vaccines are frequently substantial. This can restrict the number of companies who are prepared to invest in this field.
  • Limited Efficacy: The acceptance and market potential of some therapeutic vaccines may be constrained by their possible limited efficacy in specific patient populations or diseases.
  • Manufacturing Complexities: The production of therapeutic vaccines frequently involves intricate procedures, which might pose problems with cost-effectiveness, scalability, and consistency.
  • Patient Acceptance and Compliance: It can be difficult to get patients to accept and comply with therapeutic vaccinations, especially if they need to receive the shots frequently or have serious side effects.
  • Competition from Other Therapies: Traditional medications and other biologics, which may provide other methods to illness care, could pose a threat to therapeutic vaccinations.
  • Limited Knowledge and Education: The development of the therapeutic vaccine business may be hampered by patients' and healthcare professionals' ignorance of therapeutic vaccinations and their possible advantages.
  • Healthcare Infrastructure Difficulties: The distribution and administration of therapeutic vaccines may face difficulties in certain areas due to a lack of resources and infrastructure for healthcare.
  • Insurance Coverage and Reimbursement Issues: Patients' access to and use of therapeutic vaccinations may be hampered by inadequate insurance coverage and reimbursement, especially in areas with predominately private healthcare systems.

Global Therapeutic Vaccines Market Segmentation Analysis

The Global Therapeutic Vaccines Market is Segmented on the basis of Type of Disease Targeted, Mode of Action, Delivery Mechanism, and Geography.

Therapeutic Vaccines Market, By Type of Disease Targeted

  • Infectious Diseases: These vaccines target infectious diseases caused by viruses, bacteria, or other pathogens.
  • Cancer: Therapeutic vaccines for cancer aim to stimulate the immune system to recognize and destroy cancer cells.
  • Autoimmune Diseases: Vaccines designed to modulate the immune response in autoimmune conditions like rheumatoid arthritis or multiple sclerosis.

Therapeutic Vaccines Market, By Mode of Action

  • Immune Modulators: These vaccines work by modulating the immune system, either by activating or suppressing certain immune responses.
  • Antigen-Specific Vaccines: Targeting specific antigens associated with a disease, these vaccines train the immune system to recognize and attack the pathogen or diseased cells.
  • Cell-Based Vaccines: Utilizing cells, such as dendritic cells, to present antigens to the immune system and trigger an immune response.

Therapeutic Vaccines Market, By Delivery Mechanism

  • Traditional Vaccines: Administered via injection, similar to traditional vaccines for prevention.
  • Nanoparticle-Based Vaccines: Utilizing nanoparticles as carriers for vaccine antigens, enhancing delivery and immune response.
  • Gene-Based Vaccines: Employing genetic material, such as DNA or RNA, to encode antigens and stimulate an immune response.

Therapeutic Vaccines Market, By Geography

  • North America: Market conditions and demand in the United States, Canada, and Mexico.
  • Europe: Analysis of the Therapeutic Vaccines Market in European countries.
  • Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
  • Middle East and Africa: Examining market dynamics in the Middle East and African regions.
  • Latin America: Covering market trends and developments in countries across Latin America.

Key Players

  • The major players in the Therapeutic Vaccines Market are:
  • Merck & Co.
  • GlaxoSmithKline
  • Pfizer
  • Moderna
  • BioNTech
  • Inovio Pharmaceuticals
  • Bavarian Nordic
  • Argos Therapeutics
  • Antigenics
  • Affiris
  • Celldex Therapeutics
  • Biovest International
  • Cel-Sci
  • Celtic Pharma
  • Cytos Biotechnology
  • Curevac

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Therapeutic Vaccines Market, By Type of Disease Targeted

  • Infectious Diseases
  • Cancer
  • Autoimmune Diseases

5. Therapeutic Vaccines Market, By Mode of Action

  • Immune Modulators
  • Antigen-Specific Vaccines
  • Cell-Based Vaccines

6. Therapeutic Vaccines Market, By Delivery Mechanism

  • Traditional Vaccines
  • Nanoparticle-Based Vaccines
  • Gene-Based Vaccines

7. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

8. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

9. Competitive Landscape

  • Key Players
  • Market Share Analysis

10. Company Profiles

  • Merck & Co.
  • GlaxoSmithKline
  • Pfizer
  • Moderna
  • BioNTech
  • Inovio Pharmaceuticals

11. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

12. Appendix

  • List of Abbreviations
  • Sources and References